Brazil vs New Zealand: Cause of death, by non-communicable diseases, ages 5-14, female
Brazil
53.0%
in 2021
New Zealand
53.0%
in 2021
Brazil rank
55th
New Zealand rank
54th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Brazil
- New Zealand
How they compare
New Zealand currently reports 53.0% against 53.0% in Brazil, a difference of 0.0%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Brazil ahead.
Brazil ranks 55th and New Zealand ranks 54th of 184 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.9% | 43.8% | 1.0% | Brazil |
| 2010s | 54.3% | 49.7% | 4.6% | Brazil |
| 2020s | 53.2% | 53.1% | 0.1% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Brazil or New Zealand?
- New Zealand, at 53.0% against 53.0% in Brazil as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Brazil and New Zealand?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for Brazil and New Zealand?
- 6 years are reported by both, from 2000 to 2021.
- How do Brazil and New Zealand rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Brazil ranks 55th and New Zealand ranks 54th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.